- Sep 1, 2022
- 1 min
EMA Guidance: For Applicants/MAHs involved in GMP and GCP Inspections
- Aug 25, 2022
- 1 min
EMA: Updated EudraVigilance Registration Manual
- Aug 12, 2022
- 1 min
Europe's EDQM: Nitrosamines – Deadline Extension for all CEP Holders - Now 1 October 2023
- Jul 31, 2022
- 1 min
EMA updated Guidance: IDMP Products Management Services - Implementation Guide
- Jul 26, 2022
- 1 min
EMA Guidance: Prevention of Medicine Shortages in the EU
- Jul 26, 2022
- 1 min
EMA: Plan for Digital Hub for the European Medicines Regulatory Network
- Jun 7, 2022
- 1 min
EMA- New Guidance on Complex Clinical Trials
- May 26, 2022
- 1 min
EMA - Guideline on Treatment of Bacterial Infections
- May 17, 2022
- 1 min
EMA's IRIS Guide for Applicants - On How to Create & Submit Scientific Applications
- Apr 10, 2022
- 2 min
EMA Draft Guidance- How To Approach the Protection Clinical Trial Information System (CTIS)
- Mar 24, 2022
- 1 min
EMA Guidance on Post-Authorisation Procedural Advice for CAP users & EudraVigilance Reg. Manual
- Mar 24, 2022
- 2 min
EMA Guidance on GVP for PPP & Parallel EMA/EUnetHTA 21 Consultation
- Mar 3, 2022
- 1 min
EU Guidelines for Good Manufacturing Practice for Medicinal Products
- Mar 3, 2022
- 1 min
EU Common Standard for electronic Pproduct Information
- Jan 16, 2022
- 1 min
EMA Guidance for Applicants seeking Scientific Advice and Protocol Assistance
- Nov 14, 2021
- 1 min
Post-Authorisation Procedural Advice for Users of the Centralised Procedure – Updated guideline EMA
- Nov 7, 2021
- 1 min
Updated Guideline on Registry-Based Studies (EMA)
- Jul 29, 2021
- 1 min
Pre-Authorisation Procedural Advice for Users of the Centralised Procedure - EMA
- Jul 29, 2021
- 1 min
Guideline on Quality Documentation for Drug-Device Combination Products - EMA
- Jul 25, 2021
- 1 min
Clinical Trials Information System (CTIS) Free Webinar – EMA